HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes].

Abstract
Pharyngeal-cervical-brachial weakness (PCB) is a rare variant of Guillain-Barré syndrome (GBS) and shows a regional muscle weakness, specially in oropharynx. Mizoguchi et al. (1994) reported a GBS patient with PCB-like symptoms who had serum IgG anti-GTla antibodies in the acute phase of illness. We therefore assumed that bulbar palsy was associated with anti-GTla antibodies and made serological study in patients with GBS or Fisher's syndrome. The frequency of positive IgG anti-GTla antibody was significantly higher in patients with bulbar palsy than those without bulbar palsy. Most of the patients with IgG anti-GTla antibodies, however, had also anti-GQlb antibodies in their sera and anti-GTla antibodies were more closely associated with ophthalmoplegia than with bulbar palsy. These findings do not support that IgG anti-GTla antibodies play an important role in the pathogenesis of bulbar palsy in GBS.
AuthorsM Koga, N Yuki, K Hirata
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 37 Issue 11 Pg. 1024-6 (Nov 1997) ISSN: 0009-918X [Print] Japan
PMID9503976 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Autoantibodies
  • Gangliosides
  • Immunoglobulin G
  • trisialoganglioside GT1
Topics
  • Autoantibodies (analysis)
  • Bulbar Palsy, Progressive (etiology)
  • Gangliosides (immunology)
  • Humans
  • Immunoglobulin G (analysis)
  • Miller Fisher Syndrome (complications, immunology)
  • Polyradiculoneuropathy (complications, immunology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: